CTOs on the Move

Institut National de Sante Publique du Quebec

www.inspq.qc.ca

 
Our goal is to advance knowledge and propose crosssectoral strategies and endeavours that will improve the health and well-being of Québecers. The Institut national de santé publique du Québec (INSPQ) was created in 1998 following the adoption of its act of incorporation (RSQ, chapter I-13.1.1). Its experts come from fields as distinct as applied science, health sciences, social sciences, and humanities and work with the health and social services network to develop and pool public health knowledge and skills.
  • Number of Employees: 250-1000
  • Annual Revenue: $1-10 Million
  • www.inspq.qc.ca
  • 945, av Wolfe
    Quebec City, QC CAN G1V 5B3
  • Phone: 418.650.5115

Executives

Name Title Contact Details

Similar Companies

Capital Home Health Care

Capital Home Health Care is a Leesburg, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Beacon Behavioral Health - Baton Rouge

Beacon Behavioral Health - Baton Rouge is a Baton Rouge, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Codman Square Health Center

The mission of Codman Square Health Center is to serve as a resource for improving the physical, mental and social well-being of the community. Codman Square Health Center is an award-winning, community-based, outpatient health care and multi-service center in the heart of Dorchester. We opened our doors in 1979 with a dream: to build the best urban community in America. With a holistic and partnership-oriented approach, we ensure access to quality health care and other supportive services through a highly successful integrated model.

Northwest Medical Center

Northwest Medical Center, Inc. is a Margate, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Genalyte

Since 2007, Genalyte has been guided by the vision of taking a single drop of blood, performing panels of tests and returning accurate and reproducible results within a few minutes. We launched our first instrument in 2012 in the pharmaceutical industry and academia for a range of healthcare applications including autoimmune disease monitoring, screening of cancer biomarkers, testing for infectious agents and detecting anti-drug antibodies. By reducing tests to a microscopic size in a highly multiplex environment on the surface of silicon chips we are able to generate more information from a smaller sample in less time than conventional techniques.